Blaize Holdings, Inc. (BZAI) is an AI-enabled edge-computing and semiconductor company that listed on Nasdaq in January 2025 following a business combination with a special-purpose acquisition company. Its stock has since collapsed roughly 95% over the trailing year, and analyst coverage has been reset repeatedly. In my view, reviewing the most recent, individually attributed targets yields roughly five usable data points: B. Riley (Buy, $2.00, lowered from $4.00), Roth Capital (Buy, $2.50, lowered from $4.50), DA Davidson (Neutral, $1.00), Craig Hallum (Hold, $0.40), and Rosenblatt (Neutral, $0.40). The arithmetic mean of these is about $1.26, rounded to a $1.25 central target, with a low-to-high range of $0.40 to $2.50. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The dispersion is extreme because analysts disagree fundamentally about the business. Bulls point to a binding, roughly $70 million server agreement and the up-to-$50 million NeoTensr contract as evidence of real demand. Bears emphasize repeated guidance cuts, customer receivable-collection issues, limited cash, and Department of Justice subpoenas. Some aggregators still show higher averages (near $1.75 to $1.98 or more) because they include older targets such as $4.50 and $6.00 that were subsequently reduced; those stale figures should be treated with caution.
The stock last traded near $0.17, giving Blaize a market capitalization of only about $27 million. Reaching $1.25 would require upside of roughly 600% or more, which is a very large move by any standard and is better understood as a recovery scenario than a conventional price forecast. One thing that stands out is how the path would depend first on restoring credibility: executing on revised fiscal-2026 revenue guidance of roughly $40 million to $43 million, demonstrating collections on large customer contracts, and resolving the listing and regulatory overhangs.
The 52-week range spans roughly $0.17 to $3.68, so the stock is trading near its lows. The $0.17–$0.18 area represents near-term support, while the first meaningful resistance sits in the $0.40 zone, where several cautious analyst targets cluster. The $1.00 level is significant both psychologically and practically, because it marks the Nasdaq minimum-bid threshold. The long-term trend remains firmly negative, meaning any move toward $1.25 would first require a sustained break above multiple overhead levels. From what I see, this setup warrants close monitoring of volume and key levels.
Most analyst price targets reflect a roughly 12-month research horizon, though the wide dispersion here signals low confidence in any single path. Upcoming items worth watching include quarterly earnings (with results expected around late November 2026) and any updated guidance, progress on Nasdaq compliance and any reverse-split vote, developments in the Department of Justice matter, cash and liquidity disclosures, and analyst revisions.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The system is designed to help traders discover opportunities, monitor existing positions, and identify shifting trends more efficiently than manual screening alone. For a volatile name such as BZAI, tools that track short-term signals can complement fundamental research. I find this approach useful when evaluating names with wide analyst dispersion like this one.
The $1.25 central target is the average of recent analyst targets ranging from $0.40 to $2.50, and it sits far above the current price of about $0.17. The required move is very large, and the gulf between bullish and bearish targets reflects genuine disagreement about whether Blaize can convert its contracts into collected revenue and stabilize its balance sheet. Supporters emphasize binding customer agreements and the restructuring, while skeptics point to guidance cuts, liquidity, the listing deficiency, and subpoenas. The central target is not a guarantee or a prediction; it is a mathematical midpoint of sharply divided opinions, and investors should weigh the company's near-term survival risks as heavily as any upside scenario.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for BZAI moved out of oversold territory on November 11, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 16 similar instances when the indicator left oversold territory. In 12 of the 16 cases the stock moved higher. This puts the odds of a move higher at 75%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for BZAI just turned positive on October 22, 2026. Looking at past instances where BZAI's MACD turned positive, the stock continued to rise in 15 of 49 cases over the following month. The odds of a continued upward trend are 31%.
Following a +11.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where BZAI advanced for three days, in 80 of 133 cases, the price rose further within the following month. The odds of a continued upward trend are 60%.
BZAI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BZAI as a result. In 30 of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 36%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BZAI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
The Aroon Indicator for BZAI entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.693) is normal, around the industry mean (-1.906). P/E Ratio (-0.353) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (1.395) is also within normal values, averaging (70.383).
The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. BZAI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BZAI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware